Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.

Li, Fei

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. [electronic resource] - Nature communications 2013 - 2384 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Intramural

2041-1723

10.1038/ncomms3384 doi


Amidohydrolases--antagonists & inhibitors
Animals
Anti-Obesity Agents--pharmacology
Antioxidants--pharmacology
Bacterial Proteins--antagonists & inhibitors
Cyclic N-Oxides--pharmacology
Diet, High-Fat--adverse effects
Gene Expression Regulation
Glucose--metabolism
Intestinal Absorption--drug effects
Intestinal Mucosa--metabolism
Intestines--drug effects
Lactobacillus--drug effects
Lipid Metabolism--drug effects
Male
Mice
Mice, Knockout
Microbiota--drug effects
Obesity--drug therapy
Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors
Signal Transduction
Spin Labels
Taurocholic Acid--agonists